Search clinical trials for: enoxaparin/tinzaparin/dalteparin

Total 572 results

University of Colombo
Ministry of Health, Sri Lanka

Withdrawn

Acute Coronary Syndrome Sri Lanka Audit Project (ACSSLAP)

ST Elevation Myocardial Infarction | Acute Coronary Syndrome | Unstable Angina | Non ST Elevation Myocardial Infarction

Sri Lanka
Beni-Suef University

Unknown

Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis (DVT)

Deep Vein Thrombosis | Malignancy

Egypt
Eastern Virginia Medical School
GlaxoSmithKline

Terminated

Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients

Venous Thromboembolism
St. David's HealthCare

Completed

Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT) (XACT)

Covid19

United States
Northern Jiangsu People's Hospital

Completed

Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）

Venous Thrombosis | Cirrhosis | Hypertension, Portal | Splenectomy; Status

China
Brighton and Sussex University Hospitals NHS Trust
Medtronic Vascular

Completed

Revascularisation or Medical Therapy in Elderly Patients With Acute Anginal Syndromes (RINCAL)

Acute Coronary Syndromes

United Kingdom
Bayer

Completed

Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement (ODIXa-HIP2)

Venous Thromboembolism

Italy, Spain, Denmark, Netherlands, Belgium, Austria, Germany, Poland, Sweden, Israel, France, Norway, United Kingdom
Johns Hopkins University
GlaxoSmithKline

Completed

Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients

Pulmonary Embolism | Deep Venous Thrombosis

United States
Bayer
Janssen Research & Development, LLC

Completed

Dose-confirmatory Bridging Study in Total Hip Replacement

Venous Thromboembolism

Japan
Bayer
Janssen Scientific Affairs, LLC

Completed

Dose-confirmatory Bridging Study in Total Knee Replacement

Venous Thromboembolism

Japan
Bayer

Completed

Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin

Venous Thromboembolism

Italy, Spain, Poland, United States, Czech Republic, Canada, Denmark, Netherlands, Belgium, Chile, Slovakia, Hungary, Austria, France, Germany, South Africa, Sweden, Turkey, Colombia, Israel, Mexico, Argentina, Norway, Brazil, Lithuania, ... and more
Bayer

Completed

ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial (ODiXaHip)

Thromboembolism | Prevention

Belgium, Denmark, Austria, Germany, Netherlands, Poland, Sweden, Israel, France, Norway, United Kingdom
Bayer

Completed

Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. (RECORD 3)

Venous Thromboembolism | Prevention

Belgium, Italy, Poland, Spain, China, France, Denmark, Netherlands, Austria, Germany, Mexico, South Africa, Sweden, Colombia, Israel, Canada, Norway, Peru, Czech Republic
Fundacion GenesisCare
Hospital La Milagrosa; Hospital Vithas Valencia Consuelo

Suspended

Ultra Low Doses of Therapy With Radiation Applicated to COVID-19 (ULTRA-COVID)

Pneumonia, Viral | Cytokine Storm

Spain
Organon and Co

Completed

Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)

Acute Coronary Syndrome
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder

Panic Disorder

United States
Centre Hospitalier Universitaire de Saint Etienne
Bayer

Terminated

PROphylaxis in NOn Major Orthopaedic Surgery (PRONOMOS)

Non-major Orthopaedic Surgery

France
Medical Compression Systems

Completed

Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH) (SAFE)

Bleeding | Pulmonary Embolism (PE) | Deep Vein Thrombosis of Lower Limb

United States
Bayer

Completed

Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement (ODIXaHIP-OD)

Venous Thromboembolism

Italy, Spain, Denmark, Netherlands, Belgium, Austria, Germany, Poland, Sweden, Israel, Norway, United Kingdom, France
Boehringer Ingelheim

Completed

Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI) (ASSENT 3)

Myocardial Infarction
Centre of Postgraduate Medical Education

Unknown

Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban.

Blood Loss | Hip Osteoarthritis

Poland
The Prince Charles Hospital
Sanofi; Merck Sharp & Dohme LLC

Completed

Tirofiban and Enoxaparin in High Risk Coronary Intervention

Acute Coronary Syndrome

Australia
Cairo University
Ahmed Elgazzar Hospital

Completed

Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome

Recurrent Abortion

Egypt
Daiichi Sankyo, Inc.

Completed

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF) (ENSURE-AF)

Atrial Fibrillation

France, Italy, Poland, Ukraine, United Kingdom, United States, Belgium, Germany, Spain, Israel, Bulgaria, Romania, Netherlands, Russian Federation, Austria, Sweden, Hungary, Denmark, Czechia
Samsung Medical Center

Unknown

Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study) (ENCHASE)

Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban)

Korea, Republic of
Second Xiangya Hospital of Central South University

Completed

Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome (H-REPLACE)

Myocardial Infarction | Myocardial Ischemia | Acute Coronary Syndrome | Unstable Angina

China
Henan University of Traditional Chinese Medicine
Peking University First Hospital; Chengdu University of Traditional Chinese... and other collaborators

Unknown

Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment

Henoch-Schönlein Purpura Nephritis

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer

Lung Cancer
Bristol-Myers Squibb

Terminated

A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection

Chronic Hepatitis B

Germany, Turkey, United States, Poland, Belgium, Italy
Perosphere Pharmaceuticals Inc, a wholly owned...
Quintiles, Inc.

Completed

Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With Anticoagulants

Healthy
University Hospital, Angers

Not yet recruiting

RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing (RIVACAST)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Thromboprophylaxis | Lower Limb Trauma | Immobilisation

France
University of Iowa
Aventis Pharmaceuticals

Terminated

Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

United States
Daiichi Sankyo, Inc.

Completed

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

Pulmonary Embolism | Venous Thromboembolism (VTE) | Deep Vein Thrombosis (DVT)

United States, Israel, Spain, Czechia, Singapore, Canada, Argentina, Brazil, Bulgaria, Chile, Croatia, Denmark, El Salvador, France, Germany, Guatemala, Hungary, India, Kenya, Korea, Republic of, Lebanon, Malaysia, Netherlands, Norway, ... and more
Centre Hospitalier de PAU

Terminated

Anticoagulant Treatments and Percutaneous Coronary Angioplasty (TACA)

Coronary Artery Disease

France
Daiichi Sankyo, Inc.

Completed

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Cardiac Disease

United States, Spain, Canada, Lebanon, Turkey, Austria, Croatia, Egypt, France, Hungary, India, Israel, Ukraine, United Kingdom
Suleyman Demirel University

Completed

Sedation and Nursing Management in EEG Recording in Children

Sleep Deprivation | Electroencephalography | Melatonin | Hydroxyzine | Chloral Hydrate

Turkey
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University; New York Presbyterian Hospital

Completed

Enoxaparin Versus Aspirin in Patients With Cancer and Stroke

Cancer Patients First-ever Acute Ischemic Stroke

United States
University of Miami

Terminated

Aspirin and Enoxaparin for VTE in Trauma

Trauma | Venous Thromboembolism | Thromboprophylaxis

United States
EMS

Not yet recruiting

Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia (AUSTRÁLIA)

Erectile Dysfunction | Prostatic Hyperplasia, Benign

Brazil
Takeda

Completed

Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement

Venous Thromboembolism

United States, Canada
Seoul National University Hospital
Korea OIAA

Completed

Cilostazol Augmentation Study in Dementia

Alzheimer's Dementia

Korea, Republic of
Pfizer

Completed

Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

Venous Thrombosis

Australia, United States, Spain, Czech Republic, Portugal, Canada, South Africa, Italy, Colombia, Poland, France, Chile, Russian Federation, Denmark, United Kingdom, Slovakia
University of Arkansas
National Institutes of Health (NIH); Ortho Biotech Clinical Affairs, L.L.C.

Completed

Effects of Exercise in Combination With Epoetin Alfa

Multiple Myeloma

United States
Boehringer Ingelheim

Completed

Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement

Thromboembolism | Arthroplasty, Replacement, Knee

United States, Canada, Mexico, United Kingdom
Fertility Center of Las Vegas

Recruiting

Lovenox With Aspirin in Thawed Blastocyst Transfer

Infertility, Female

United States
University of Khartoum

Unknown

Aspirin, Heparin and Miscarriage

Pregnancy | Miscarriage

Libyan Arab Jamahiriya
Jong Woo Chung
Asan Medical Center; SK Chemicals Co., Ltd.

Terminated

Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy (REREV)

Recurrent Vestibulopathy

Korea, Republic of
Eurnekian Public Hospital

Completed

Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19 (IDEA)

Severe Acute Respiratory Syndrome | Ventilation Pneumonitis

Argentina
Pejman Ghanouni

Terminated

Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors

Soft Tissue Neoplasms

United States
The First Affiliated Hospital with Nanjing Medical...
National Natural Science Foundation of China

Completed

OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial (OPTIMA-2)

Coronary Artery Disease

China

Search clinical trials for: enoxaparin/tinzaparin/dalteparin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations